摘要
目的 初步揭示天津市循环系疾病死亡的分布情况。方法 将天津市 1992～ 2 0 0 1年循环系疾病死亡状况进行汇总分析 ,应用死亡率及潜在寿命损失年数 (PYLL)揭示 10年的动态变化。结果 近 10年来循环系疾病死亡率及PYLL均呈上升趋势 ,两类指标顺位前 3位分别为脑血管病、急性心肌梗死、其他冠心病及脑血管病、急性心肌梗死、慢性风湿性心脏病 ;年龄别死亡率有随年龄增长的趋势 ,PYLL随年龄变化的情况则不尽相同 ;各类疾病中脑血管病、急性心肌梗死、其他冠心病、其他心脏病死亡率呈上升趋势 ,慢性风湿性心脏病、高血压性心脏病、肺源性心脏病、其他高血压病死亡率呈下降趋势 ;慢性风湿性心脏病、肺源性心脏病 ,死亡率及PYLL两类指标表现出了不同的含意。结论 应提高天津市脑血管病、急性心肌梗死的诊治水平 ,控制死亡率 ;慢性风湿性心脏病 ,肺源性心脏病的工作重点应在预防早死上。
Objective To explore the distribution situation of the death of circulatory system diseases.Methods This study analyzed 10-year (1992～2001) diseases of circulatory system mortality trends,and disclosed the 10-year death trend by using death rate and person-years of life lost (PYLL).Results Tabulated data of specific disease deaths during the study period were provided by Tianjin Vital Statistics Unit,Tianjin Health Bureau.The specific person-year of life lost (PYLL) for selected diseases of circulatory system and the changes in PYLL over time was examined to assess the impact of each individual diseases of circulatory system on the study population.The results showed that both the overall diseases of circulatory system mortality and the PYLL increased during the study period;there were substantial variations in these changes of the diseases of circulatory system sties.In a descending order,the three leading diseases of circulatory system are diseases of brain blood vessel,acute myocardial infarction,rest coronary heart disease for mortality and diseases of brain blood vessel,a cute myocardial infarction,and tardiness rheumatic heart disease for PYLL.The results showed that diseases of circulatory system mortality increased with age;nevertheless,the changes in PYLL were not consistent with age.Conclusion Diseases of brain blood vessel,acute myocardial infarction,rest coronary heart diseases,rest heart diseases had an annual increase in mortality;Rheumatic heart disease,hypertensive heart diseases,pulmonary heart disease,rest hypertension had an annual declined in mortality.An opposite change pattern for mortality and PYLL was observed for rheumatic heart disease and pulmonary heart disease.
出处
《中国全科医学》
CAS
CSCD
2004年第17期1236-1239,共4页
Chinese General Practice
